meerecompany미래컴퍼니

meerecompany's revenue has shrunk for three years and it remains loss-making, though the share price has recently held up better than over the past year.

The Korean equipment maker, which makes panel-processing machines and touch panels and is expanding into surgical robots, posted a trailing twelve-month operating loss of ₩5.4B on revenue of ₩67.5B through H1 2026. Revenue fell about 39% in 2025 and the company has moved from profit in 2022 to losses since 2024. The shares closed at ₩9,560 on 27 October 2026, down 41.6% over one year but up 3.6% over three months, with a market value of about ₩84.3B.

What stands out

• Trailing operating margin is -8% and net margin is -4.7%, a narrower loss than the full-year 2025 operating margin of -60.4%.
• Cash of ₩21.5B exceeds borrowings of ₩5.1B, but trailing free cash flow was -₩6.3B, so cash is being used up.
• Price-to-book is about 0.8 and the company pays no dividend; price-to-earnings is not meaningful because earnings are negative.
• Filings in 2026 include a half-year report, a quarterly report, and an amended major sales or supply contract, but the data does not describe the contract's size or customer.
• No recent news headlines are in the data, so there is no press coverage to weigh alongside the filings.
• Over 20 days, foreign and institutional investors were net sellers while retail investors were net buyers; foreign ownership rose slightly to 3.1%.

What to watch

• The next results and the full H1 2026 half-year report details, including whether losses keep narrowing from the 2025 level.
• Whether free cash flow turns positive, since cash on hand is larger than borrowings but the trailing free cash flow is negative.
• Details of the amended supply contract and progress of the surgical robot business, which the data does not quantify.